Ann: Genex receives NBIO from J-POWER, page-29

Unfortunately I know and I have resisted (voted no) to no avail in a number of recent SOA deals where ASX listed companies have been grabbed for what is really 'cheap' price under SOA, so one has no opportunity to stay in.
Aactually, it not so much small holders accepting, but just not voting at all at SOA meeting, as in many cases, if small all small holders voted No, itthere would be sufficient votes on 'number of shareholders' count to block deal.

In my cases, one has been a loyal longterm investor, stuck around through the 'downs' because I felt it would ultmately have a good future and it was 'locally owned', only tyo see it sold out for a pittance value (when you look at the actual cost to OS buyer in their currency) before shareholders have a chance to benefit from all the had yards put in. I am thinking of Nearmap, recent attempt to grab LTR and another one a couple of years ago (Acciona? I think.

So yes, I am feeling rather jaded about it and need to release 'steam'.
Just hoping that same thing does not happen to some ASX biotech companies where one has been longterm holder that are 'just starting to head towards profitability' and they have a good portfolio of developments that should be ready to market in the future.